Ramin Farzaneh-Far
Directeur Technique/Scientifique/R&D chez RA PHARMACEUTICALS, INC.
Profil
Ramin Farzaneh-Far is a Venture Partner at RA Capital where he works closely with RA’s Venture Team to evaluate drug discovery platforms and initiate novel therapeutics programs.
He was Chief Medical Officer of Ra Pharmaceuticals from 2016 until it was acquired by UCB in 2020.
Ramin is an experienced clinical trialist and previously led global clinical development programs at Akebia Therapeutics and Gilead Sciences.
A trained cardiologist, he has held academic faculty positions at the University of California, San Francisco (UCSF) and the University of Texas Southwestern Medical Center.
Ramin completed his internal medicine residency at Brigham & Women’s Hospital in Boston and trained in cardiovascular medicine at UCSF.
He holds BA and MA degrees in immunology from the University of Cambridge, an MD from University College London, and an MAS in clinical research from UCSF.
Postes actifs de Ramin Farzaneh-Far
| Sociétés | Poste | Début |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2016 |
Pepgen Ltd.
 Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Président | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Private Equity Investor | 01/01/2020 |
Anciens postes connus de Ramin Farzaneh-Far
| Sociétés | Poste | Fin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2016 |
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/09/2015 |
| PEPGEN INC. | Président | - |
Arcuate Therapeutics, Inc.
 Arcuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcuate Therapeutics, Inc. engages in the pharmaceutical industry. The company is headquartered in Boston, MA. | Directeur/Membre du Conseil | - |
Formation de Ramin Farzaneh-Far
| University of Cambridge | Graduate Degree |
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| PEPGEN INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Pepgen Ltd.
Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Technology Services |
Arcuate Therapeutics, Inc.
Arcuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcuate Therapeutics, Inc. engages in the pharmaceutical industry. The company is headquartered in Boston, MA. | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
